Allara Raises $26M to Expand Women’s Hormone Telehealth
A Personal Journey Inspires a New Approach to Women's Health
Rachel Blank’s upbringing, with a father practicing as an OB-GYN, led her to believe that comprehensive gynecological care was universally accessible to women. She often observed her father receiving gratitude from patients whose deliveries he had overseen.
However, Blank’s perspective shifted when she received a diagnosis of polycystic ovary syndrome (PCOS) at the age of 21. This reproductive and hormonal condition is often associated with irregular menstrual cycles, potential infertility, and weight fluctuations.
The Gap in Specialized Care
Despite having access to high-quality healthcare, Blank discovered a significant deficiency in the training of many OB-GYNs regarding hormonal imbalances. “Finding a specialist for my specific condition proved difficult, as the concept was largely nonexistent at the time,” she explained to TechCrunch.
Blank was compelled to independently research treatment options, consulting with a range of healthcare professionals, including dieticians and endocrinologists, to formulate a personalized care plan.
The Birth of Allara
Driven by her experience, Blank departed from her role as a director of strategy at Ro, a telehealth company specializing in areas like erectile dysfunction and menopause, to establish Allara over four years ago.
Allara is a telehealth platform designed to provide comprehensive care for women experiencing hormone-related conditions such as PCOS, endometriosis, and hypothyroidism. The platform aims to consolidate the fragmented care Blank herself had to assemble.
Rapid Growth and Investment
The startup’s model has proven successful, particularly among younger demographics, with an average patient age of 30. Allara experienced a four-fold increase in revenue in 2024.
This growth has been recognized by investors, leading to a recent $26 million Series B funding round spearheaded by Index Ventures, with participation from GV, just 14 months after securing a $10 million Series A.
Expanding Access Through Insurance
Initially launched as a direct-to-consumer subscription service, Allara has strategically partnered with major health insurance providers over the past year.
These partnerships, including agreements with Aetna, Blue Cross Blue Shield, Cigna, Humana, and United Healthcare, now enable coverage of Allara’s services in 10 states. The new funding will be utilized to broaden insurance accessibility nationwide.
Benefits for Both Patients and Providers
Allara’s integrated approach, encompassing consultations with diverse specialists, appeals not only to patients but also to healthcare professionals.
Doctors, nurse practitioners, dermatologists, and registered dieticians – many of whom are working mothers – appreciate the flexibility of remote patient care, eliminating the need for travel to traditional clinic settings.
Differentiating from Competitors
While several startups, including Tia, Midi Health, Gennev, and Ro, offer online treatment for hormonal conditions, their focus often centers on infertility or menopause.
Allara distinguishes itself by primarily serving women navigating chronic hormonal conditions before they begin planning for pregnancy.
Long-Term Vision
Index partner Martin Mignot highlighted the significance of Allara’s younger patient base, anticipating long-term patient loyalty.
“Establishing a relationship with care providers in one’s 20s or 25s naturally fosters continuity of care over time,” Mignot stated. This suggests potential future expansion into areas like infertility and menopause as patients’ needs evolve.